These compounds may interact with:
Macrophage colony-stimulating factor 1 receptor
Potentially involved in: cancer; immune system cancer; brain cancer; hematologic cancer; carcinoma; pigmented villonodular synovitis; congenital myasthenic syndrome 4c; atherosclerosis; pre-eclampsia; osteopetrosis; coronary artery disease; malignant histiocytosis; congenital myasthenic syndrome 6; arthritis; neurodegenerative disease; brain disease; pertussis; apraxias; depressive disorder; gliosis
Disease data sourced from Pharos.